Ignite Creation Date:
2024-05-06 @ 6:16 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05605678
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2022-10-31
Brief Title:
Hemophilia Non-Interventional Study Prior to SerpinPC Intervention PRESent-5
Sponsor:
ApcinteX Ltd
Organization:
ApcinteX Ltd
Study Overview
Official Title:
A Global Non-interventional Study to Prospectively Evaluate Bleeding Episodes and Treatment Use in Patients With Hemophilia
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to obtain prospective baseline documentation of annualized bleeding rates ABRs and treatment under standard-of-care SOC therapy among participants with hemophilia A or B Participants in the study may be eligible to enroll in future planned interventional studies to be conducted by Sponsor
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None